1. Home
  2. KURA vs MGIC Comparison

KURA vs MGIC Comparison

Compare KURA & MGIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KURA
  • MGIC
  • Stock Information
  • Founded
  • KURA 2014
  • MGIC 1983
  • Country
  • KURA United States
  • MGIC Israel
  • Employees
  • KURA N/A
  • MGIC N/A
  • Industry
  • KURA Biotechnology: Biological Products (No Diagnostic Substances)
  • MGIC Computer Software: Prepackaged Software
  • Sector
  • KURA Health Care
  • MGIC Technology
  • Exchange
  • KURA Nasdaq
  • MGIC Nasdaq
  • Market Cap
  • KURA 700.5M
  • MGIC 788.0M
  • IPO Year
  • KURA N/A
  • MGIC 1991
  • Fundamental
  • Price
  • KURA $8.22
  • MGIC $19.64
  • Analyst Decision
  • KURA Buy
  • MGIC Buy
  • Analyst Count
  • KURA 14
  • MGIC 2
  • Target Price
  • KURA $24.45
  • MGIC $18.00
  • AVG Volume (30 Days)
  • KURA 2.0M
  • MGIC 44.7K
  • Earning Date
  • KURA 11-06-2025
  • MGIC 08-13-2025
  • Dividend Yield
  • KURA N/A
  • MGIC 2.87%
  • EPS Growth
  • KURA N/A
  • MGIC 16.93
  • EPS
  • KURA N/A
  • MGIC 0.78
  • Revenue
  • KURA $83,279,000.00
  • MGIC $584,528,000.00
  • Revenue This Year
  • KURA $60.25
  • MGIC $11.11
  • Revenue Next Year
  • KURA $155.10
  • MGIC $6.83
  • P/E Ratio
  • KURA N/A
  • MGIC $25.08
  • Revenue Growth
  • KURA N/A
  • MGIC 11.98
  • 52 Week Low
  • KURA $5.41
  • MGIC $10.24
  • 52 Week High
  • KURA $21.40
  • MGIC $22.00
  • Technical
  • Relative Strength Index (RSI)
  • KURA 66.50
  • MGIC 45.20
  • Support Level
  • KURA $7.86
  • MGIC $19.10
  • Resistance Level
  • KURA $8.52
  • MGIC $20.85
  • Average True Range (ATR)
  • KURA 0.45
  • MGIC 0.52
  • MACD
  • KURA 0.07
  • MGIC -0.09
  • Stochastic Oscillator
  • KURA 80.89
  • MGIC 42.01

About KURA Kura Oncology Inc.

Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.

About MGIC Magic Software Enterprises Ltd.

Magic Software Enterprises Ltd is a software development company. The company's operating segment includes Software Services and IT Professional Services. The company generates maximum revenue from the IT Professional Services segment. IT Professional Services segment offers IT services in the areas of infrastructure design and delivery, application development, technology planning and implementation services, communications services and solutions, as well as supplemental outsourcing services. Geographically, it derives a majority of revenue from the United States and also has a presence in Israel, Europe, Japan, and Other countries.

Share on Social Networks: